1. Medtech Insight
  2. >>Policy & Regulation

The Big Health Care Conundrum: How To Sustainably Unlock The Value Of Diagnostics

Novo holdings panel asks diagnostics industry leaders how to keep the focus on testing post-pandemic

 
• By Ashley Yeo

How can stakeholders capitalize on this moment of acute public awareness of diagnostics to improve adoption of tests and screening in the long term? At a recent roundtable event, the CEOs of Roche Diagnostics, GE Healthcare, Labcorp and Synlab, among others, gave their thoughts on how the system must change.

colorful paper with question mark as background.
• Source: Alamy

It is never a bad time to spotlight the value of early and effective diagnosis, the benefits of which extend far beyond the innovator, beyond individual patients and to national economies and wider society. While COVID-19 has wrought unprecedented global disruption, the pandemic has also demonstrated the importance and the value the diagnostics industry has created for society.

That was the contention of Boston Consulting Group’s Ulrik Schulze, in a foreword to a high-level panel hosted by Novo...

More from Policy & Regulation

More from Medtech Insight

Ochsner Surgeon In ‘The Big Easy’ Eases Patient’s Pain With Skill And Virtual Reality

 
• By Brian Bossetta

A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.

Execs On The Move: June 30–July 4, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

FDA Commissioner’s Voucher Program Should Include Devices, Transplant Technology Firm Says

 
• By Elizabeth Orr

The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.